Literature DB >> 16275130

Cloning, expression, and purification of recombinant bovine rotavirus hemagglutinin, VP8*, in Escherichia coli.

Alexsandra R M Favacho1, Eleonora Kurtenbach, Silvia I Sardi, Vera S Gouvea.   

Abstract

Rotavirus VP8* subunit is the minor trypsin cleavage product of the spike protein VP4, which is the major determinant of the viral infectivity and neutralization. To study the structure-function relationship of this fragment and to obtain type-specific reagents, substantial amounts of this protein are needed. Thus, full-length VP8* cDNA, including the entire trypsin cleavage-encoding region in gene 4, was synthesized and amplified by RT-PCR from total RNA purified from bovine rotavirus strain C486 propagated in MA104 cell culture. The extended VP8* cDNA (VP8ext) was cloned into the pGEM-T Easy plasmid and subcloned into the Escherichia coli expression plasmid pET28a(+). The correspondent 30 kDa protein was overexpressed in E. coli BL21(DE3)pLysS cells under the control of the T7 promoter. The identity and the antigenicity of VP8ext were confirmed on Western blots using anti-His and anti-rotavirus antibodies. Immobilized Ni-ion affinity chromatography was used to purify the expressed protein resulting in a yield of 4 mg of VP8ext per liter of induced E. coli culture. Our results indicate that VP8ext maintained its native antigenicity and specificity, providing a good source of antigen for the production of P type-specific immune reagents. Detailed structural analysis of pure recombinant VP8 subunit should allow a better understanding of its role in cell attachment and rotavirus tropism. Application of similar procedure to distinct rotavirus P serotypes should provide valuable P serotype-specific immune reagents for rotavirus diagnostics and epidemiologic surveys.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275130     DOI: 10.1016/j.pep.2005.09.014

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

1.  Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus.

Authors:  Khadijeh Nasiri; Mohammadreza Nassiri; Mojtaba Tahmoorespur; Alireza Haghparast; Saeed Zibaee
Journal:  Adv Pharm Bull       Date:  2016-03-17

2.  Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis.

Authors:  Li Zhang; Binyang Zheng; Xingsu Gao; Libo Zhang; Hongxin Pan; Yong Qiao; Guangli Suo; Fengcai Zhu
Journal:  Front Immunol       Date:  2020-11-13       Impact factor: 7.561

3.  Isolation and Characterization of Bovine RVA from Northeast China, 2017-2020.

Authors:  Xi Cheng; Wei Wu; Fei Teng; Yue Yan; Guiwei Li; Li Wang; Xiaona Wang; Ruichong Wang; Han Zhou; Yanping Jiang; Wen Cui; Lijie Tang; Yijing Li; Xinyuan Qiao
Journal:  Life (Basel)       Date:  2021-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.